SE9303784D0 - Igf - Google Patents

Igf

Info

Publication number
SE9303784D0
SE9303784D0 SE9303784A SE9303784A SE9303784D0 SE 9303784 D0 SE9303784 D0 SE 9303784D0 SE 9303784 A SE9303784 A SE 9303784A SE 9303784 A SE9303784 A SE 9303784A SE 9303784 D0 SE9303784 D0 SE 9303784D0
Authority
SE
Sweden
Prior art keywords
igf
pct
date
insulin
sec
Prior art date
Application number
SE9303784A
Other languages
English (en)
Swedish (sv)
Inventor
Bjoern Nilsson
Sophia Elisabeth Hober
Original Assignee
Kabi Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabi Pharmacia Ab filed Critical Kabi Pharmacia Ab
Priority to SE9303784A priority Critical patent/SE9303784D0/xx
Publication of SE9303784D0 publication Critical patent/SE9303784D0/xx
Priority to NZ276520A priority patent/NZ276520A/en
Priority to US08/646,365 priority patent/US5683980A/en
Priority to EP95901661A priority patent/EP0736040B1/de
Priority to PCT/SE1994/001076 priority patent/WO1995014034A1/en
Priority to AT95901661T priority patent/ATE190627T1/de
Priority to AU10808/95A priority patent/AU684117B2/en
Priority to DE69423516T priority patent/DE69423516T2/de
Priority to FI962081A priority patent/FI962081A7/fi
Priority to JP51439095A priority patent/JP3609410B2/ja
Priority to CA002176599A priority patent/CA2176599A1/en
Priority to NO961995A priority patent/NO961995D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
SE9303784A 1993-11-16 1993-11-16 Igf SE9303784D0 (sv)

Priority Applications (12)

Application Number Priority Date Filing Date Title
SE9303784A SE9303784D0 (sv) 1993-11-16 1993-11-16 Igf
CA002176599A CA2176599A1 (en) 1993-11-16 1994-11-14 Use of igf-bp for refolding of igf
PCT/SE1994/001076 WO1995014034A1 (en) 1993-11-16 1994-11-14 Use of igf-bp for refolding of igf
US08/646,365 US5683980A (en) 1993-11-16 1994-11-14 Use of IGF-BP for refolding of IGF
EP95901661A EP0736040B1 (de) 1993-11-16 1994-11-14 Verwendung von igf-bp zur rückfaltung von igf
NZ276520A NZ276520A (en) 1993-11-16 1994-11-14 Use of insulin like growth factor binding protein (igf-bp) for re-folding insulin like growth factor (igf)
AT95901661T ATE190627T1 (de) 1993-11-16 1994-11-14 Verwendung von igf-bp zur rückfaltung von igf
AU10808/95A AU684117B2 (en) 1993-11-16 1994-11-14 Use of IGF-BP for refolding of IGF
DE69423516T DE69423516T2 (de) 1993-11-16 1994-11-14 Verwendung von igf-bp zur rückfaltung von igf
FI962081A FI962081A7 (fi) 1993-11-16 1994-11-14 IGF-BP:n käyttö IGF:n uudelleenlaskostamiseen
JP51439095A JP3609410B2 (ja) 1993-11-16 1994-11-14 「インシュリン様成長因子（ｉｇｆ）を再折り畳みする方法」
NO961995A NO961995D0 (no) 1993-11-16 1996-05-15 Anvendelse av IGF-BP for renaturering av IGF

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9303784A SE9303784D0 (sv) 1993-11-16 1993-11-16 Igf

Publications (1)

Publication Number Publication Date
SE9303784D0 true SE9303784D0 (sv) 1993-11-16

Family

ID=20391767

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9303784A SE9303784D0 (sv) 1993-11-16 1993-11-16 Igf

Country Status (12)

Country Link
US (1) US5683980A (de)
EP (1) EP0736040B1 (de)
JP (1) JP3609410B2 (de)
AT (1) ATE190627T1 (de)
AU (1) AU684117B2 (de)
CA (1) CA2176599A1 (de)
DE (1) DE69423516T2 (de)
FI (1) FI962081A7 (de)
NO (1) NO961995D0 (de)
NZ (1) NZ276520A (de)
SE (1) SE9303784D0 (de)
WO (1) WO1995014034A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5789547A (en) * 1995-06-07 1998-08-04 Celtrix Pharmaceuticals, Inc. Method of producing insulin-like growth factor-I (IGF-I) and insulin-like growth factor binding protein-3 (IGFBP-3) with correct folding and disulfide bonding
US6417330B1 (en) 1998-06-01 2002-07-09 Celtrix Pharmaceuticals, Inc. Insulin-like growth factor binding protein variants
JP3734634B2 (ja) * 1999-03-03 2006-01-11 ヒゲタ醤油株式会社 タンパク質の活性化方法及び該装置
KR20020074749A (ko) * 2001-03-21 2002-10-04 한국생명공학연구원 재조합 인슐린 유사성장인자-1의 대량 생산방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8826451D0 (en) * 1988-11-11 1988-12-14 Sandoz Ltd Improvements in/relating to organic compounds
US5158875A (en) * 1989-08-25 1992-10-27 Amgen Inc. Production of biologically active insulin-like growth factor i from high expression host cell systems
WO1992014834A1 (en) * 1991-02-14 1992-09-03 The Whittier Institute For Diabetes And Endocrinology Insulin-like growth factor binding protein
US5288931A (en) * 1991-12-06 1994-02-22 Genentech, Inc. Method for refolding insoluble, misfolded insulin-like growth factor-I into an active conformation
WO1993019084A1 (en) * 1992-03-24 1993-09-30 Synergen, Inc. Refolding and purification of insulin-like growth factor i
US5407913A (en) * 1992-12-03 1995-04-18 Celtrix Pharmaceuticals, Inc. Method and composition for systemic treatment of tissue injury

Also Published As

Publication number Publication date
JP3609410B2 (ja) 2005-01-12
US5683980A (en) 1997-11-04
NO961995L (no) 1996-05-15
AU1080895A (en) 1995-06-06
ATE190627T1 (de) 2000-04-15
EP0736040A1 (de) 1996-10-09
NO961995D0 (no) 1996-05-15
DE69423516D1 (de) 2000-04-20
FI962081L (fi) 1996-07-15
EP0736040B1 (de) 2000-03-15
JPH09505077A (ja) 1997-05-20
CA2176599A1 (en) 1995-05-26
FI962081A0 (fi) 1996-05-15
NZ276520A (en) 1997-11-24
DE69423516T2 (de) 2000-09-14
WO1995014034A1 (en) 1995-05-26
AU684117B2 (en) 1997-12-04
FI962081A7 (fi) 1996-07-15

Similar Documents

Publication Publication Date Title
ATE81779T1 (de) Peptidanalogedes insulinaehnlichen wachstumsfaktors-1 bei saeugetieren.
FR2678624B1 (de)
DK408089D0 (da) Proteiner
DK0749478T3 (da) Gærstammer og modificerede albuminer
ATE184776T1 (de) Biokompatibles implantat für die zeitliche abstimmung der ovulation von stuten
DE69130506D1 (de) Nukleotidsequenzen kodierend für ein humanes protein mit angiogenetisch-regulatorischen eigenschaften
ES2140463T3 (es) Prevencion y tratamiento de la neuropatia periferica.
AU1955388A (en) Method for potentiating and inhibiting insulin-like growth factor activity
AU1422492A (en) Pea protein hydrolyzate, method for production thereof and use thereof
ATE178072T1 (de) Neuartige polypeptide und ihre verwendung
DE69323204D1 (de) Verwendung von spezifischen molekülen zur steigerung der igf-1 aktivität
ATE301714T1 (de) Insulinartigen wachstumsfaktor bindendes protein -3 variante
SE9303784D0 (sv) Igf
CO4700528A1 (es) Peptidos de somatostatina
DE69333063D1 (de) Vekürztes insulinähnlichen wachstumsfaktor-bindendes protein mit mitogener aktivität
ATE165619T1 (de) Rekombinante antikörper an der oberfläche von e.coli
DK0561877T3 (da) Forbindelser og præparater der hæmmer knogleresorption
NO970113L (no) Kollagenbindende protein eller polypeptid
GB2249312B (en) Cell growth inhibitors
AU6750990A (en) A protein purification method
GB2262528B (en) Further improvements relating to the radiolabelling of proteins
DE69102069D1 (de) 5-aminosalicylsäurederivate zur therapie chronisch entzündlicher baucherkrankungen.
SE9303068D0 (sv) New use
ATE294189T1 (de) Kristallisation von proteinen
SE8501202D0 (sv) Human intestinal hormone and its use